| J0897 | Injection, denosumab, 1 mg | 6,000 | $20 | $108K |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 6,300 | $20 | $107.1K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 2,210 | $40 | $84K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 3,990 | $10 | $31.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 3,100 | $10 | $31K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 210 | $90 | $18K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 70 | $140 | $10.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 140 | $50 | $6.7K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 60 | $60 | $3.4K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 20 | $160 | $2.4K |